Loading...
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
BACKGROUND: Amyloid-β positron emission tomography (PET) and cerebrospinal fluid (CSF) Aβ(42) are considered interchangeable for clinical diagnosis of Alzheimer’s disease. OBJECTIVE: To explore the clinical reasoning for requesting additional amyloid-β PET after performing CSF biomarkers. METHODS: W...
Na minha lista:
| Udgivet i: | J Alzheimers Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
IOS Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7081099/ https://ncbi.nlm.nih.gov/pubmed/31796674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-190836 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|